John Revill
Stories by John Revill
Swiss court convicts two execs in Malaysia’s $1.8b 1MDB fraud
Swiss-Saudi Tarek Obaid and Patrick Mahony are said to have pocketed at least $805m and $37m, respectively.
UBS expects to complete Credit Suisse acquisition as early as June 12
UBS had been rushing to close the transaction, hoping to provide greater certainty for Credit Suisse clients.
Syngenta shifts IPO application to main board of Shanghai stock exchange
Syngenta is seeking to rescue its $9.4b IPO.
Sergio Ermotti returns as UBS CEO to drive Credit Suisse takeover
He takes charge weeks after UBS bought its Swiss rival in a shotgun merger.
Agrichemical giant Syngenta moves closer to $9.5b IPO with Shanghai bourse hearing
Syngenta was bought for $43b by ChemChina in 2017.
Credit Suisse approaches Middle Eastern sovereign wealth fund for capital
Credit Suisse's investment banking chief will be leaving on Oct. 27.
Adani to become India’s second-biggest cement maker with $10.5b Holcim deal
Adani has acquired 63.19% of Ambuja Cements and its subsidiary ACC.
Syngenta’s planned IPO in China suspended for missing financial info
The company's application to list on Shanghai's STAR Market was accepted at the start of July.
Syngenta to use proceeds from $10b Shanghai IPO for acquisitions, growth
The flotation will value the Swiss company at about $60b including debt.
ChemChina looks to raise $10b from Shanghai IPO of agrichemical firm Syngenta
The listing could possibly be one of the world's largest floats this year.
